-
BLALOCK
1
SUSAN J. BLALOCK, Ph.D.
Curriculum Vitae
May 2012
PERSONAL DATA
Office Address:
Pharmaceutical Outcomes and Policy
UNC Eshelman School of Pharmacy,
Kerr Hall, CB# 7360
University of North Carolina
Chapel Hill, NC 27599-7573
Phone: 919-962-0080
Email: [email protected]
Home Address:
32 Mossy Lane
Pittsboro, NC 27312
Phone: 919-933-5683
EDUCATION
University of North Carolina at Chapel Hill
Department of Health Behavior and Health Education
School of Public Health
Ph.D. 1987
University of Michigan, Ann Arbor
Department of Health Behavior and Health Education
School of Public Health
M.P.H. 1980
University of Michigan, Ann Arbor
College of Pharmacy
B.S.Pharm. 1976
CURRENT APPOINTMENTS
University of North Carolina at Chapel Hill
Eshelman School of Pharmacy
Professor
Division of Pharmaceutical Outcomes and Policy
January 2012-Present
University of North Carolina at Chapel Hill
Eshelman School of Pharmacy
Vice Chair
Division of Pharmaceutical Outcomes and Policy
January 2011-Present
University of North Carolina at Chapel Hill
Eshelman School of Pharmacy
Associate Professor
Division of Pharmaceutical Outcomes and Policy
July 2002-January 2012
-
BLALOCK
2
University of North Carolina at Chapel Hill
School of Public Health
Adjunct Instructor
Department of Health Behavior and Health Education
November 2003-Present
PREVIOUS PROFESSIONAL EXPERIENCE
1998-2002: Associate Professor, Department of Pharmacy Practice,
Thomas J. Long School
of Pharmacy and Health Sciences, University of the Pacific,
Stockton, CA.
1996-1998: Research Associate Professor, Department of Health
Behavior and Health
Education, School of Public Health, University of North
Carolina, Chapel Hill, NC.
1994-1998: Research Associate, Thurston Arthritis Research
Center, School of Medicine,
University of North Carolina, Chapel Hill, NC.
1994-1996: Research Assistant Professor, Department of Health
Behavior and Health
Education, School of Public Health, University of North
Carolina, Chapel Hill, NC.
1992-1998: Director, Numerical Sciences Core, Thurston Arthritis
Research Center,
University of North Carolina, Chapel Hill, NC.
1987-1994: Adjunct Assistant Professor, Department of Health
Behavior and Health
Education, School of Public Health, University of North
Carolina, Chapel Hill, NC.
1987-1994: Assistant Director for Education, Department of
Physical Medicine and
Rehabilitation, School of Medicine, University of North
Carolina, Chapel Hill, NC.
1985-1987: Arthritis Health Professions Trainee, Department of
Health Behavior and
Health Education, School of Public Health, University of North
Carolina, Chapel Hill,
NC.
1982-1985: Research Assistant, Department of Health Behavior and
Health Education,
School of Public Health, University of North Carolina, Chapel
Hill, NC.
1981: Health Education Intern, Veterans Administration Medical
Center, Ann Arbor, MI.
1980: Research Assistant, Departments of Epidemiology and
Community Health, School of
Public Health, University of Michigan, Ann Arbor, MI.
1976-1989: Pharmacist, Community Pharmacy Practice.
HONORS
Longs Fellowship, University of the Pacific, 2001
Clifford M. Clarke Science Award for top ranked clinical science
grant application (of 41
reviewed), National Arthritis Foundation, 2000
Rho Chi (Pharmacy Honor Society), Inducted 1999
Bernard G. Greenberg Award for Excellence in Doctoral Research
from the School of Public
Health, University of North Carolina at Chapel Hill, 1988
Arthritis Health Professions Traineeship, 1985-87
Delta Omega (Public Health Honor Society), Inducted 1985
-
BLALOCK
3
BIBLIOGRAPHY
Book Chapters
Blalock SJ, Sleath B. Risk Evaluation and Communication. In
Strom BL, Kimmel SE,
Hennessey S, eds. Pharmacoepidemiology, 5th
ed. Oxford: Wiley & Sons, 2012.
Blalock SJ, Keller S. Consumer Assessment of Pharmacy Quality.
In Warholak TL, Nau
DP, eds. Pharmacy Quality: Improving the Safety and
Effectiveness of Pharmacy
Services. London: McGraw-Hill; 2010.
Blalock SJ, Beard AJ, Dusetzina SB. Individual/Interpersonal
Models of Health and Illness
Behavior. In Rickles NM, Wertheimer AI, Smith M, eds. Social and
Behavioral
Aspects of Pharmaceutical Care, 2nd
. Edition. Sudbury, MA: Jones and Bartlett, 2010.
DeVellis RF, Blalock SJ. Outcomes of Self-Management
Interventions. In Newman S,
Steed E, Mulligan K eds. Chronic Physical Illness:
Self-Management and Behavioural
Interventions. London: McGraw-Hill; 2008.
Weinstein ND, Sandman PM, Blalock SJ. The Precaution Adoption
Process Model. In
Glanz K, Rimer BK, Lewis FM, eds. Health Behavior and Health
Education: Theory,
research and practice. San Francisco: Jossey-Bass;
2008:123-147.
DeVellis BM, Revenson TA, Blalock SJ. Rheumatic disease and
women's health. In:
Gallant S, Keita GP, Royak-Schaler R, eds. Health Care for
Women: Psychological,
Social and Behavioral Influences. Washington DC: American
Psychological
Association Press; 1997:333-347.
DeVellis RF, Blalock SJ. Psychological and educational
interventions to reduce
arthritisdisability. In: Newman S, Shipley M, eds. Clinical
Rheumatology (Vol 7):
Psychological Aspects of Rheumatic Disease. London: Bailliere
Tindall; 1993:397-416.
Refereed Papers (80 total, including in press)
Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O’Connor
SK. The effect of
community pharmacy-based interventions on patient health
outcomes. Med Care Res
Rev, in press
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines,
RCM, Coker-
Schwimmer EJL, Rosen DL, Sista P, Lohr KN. Interventions to
improve adherence to
self-administered medications for chronic diseases: a systematic
review. Ann Int Med,
in press
Elstad EA, Carpenter DM, DeVellis RF, Blalock SJ. Patient
decision making in the face of
conflicting medication information. Int J Qual Stud Health
Well-being, in press.
Carpenter SM, Blalock SJ, DeVellis RF. Do patients with a rare
disease use pharmacists for
medication information? J Am Pharm Assoc, in press
Carpenter DM, Elstad EA, Blalock S, DeVellis RF. Conflicting
medication information:
Prevalence, sources and relationship to medication adherence. J
Health Commun, in
press.
Blalock SJ, Keller S, Nau D, Frentzel EM. Development of the
Consumer Assessment of
Pharmacy Services survey. J Am Pharm Assoc, 2012;52(3):324-32.
PMID: 22618972
-
BLALOCK
4
Sleath BL, Blalock SJ, Stone JG, Skinner AC, Covert D, Muir K,
Robin AL. Validation of a
Short Version of the Glaucoma Medication Self-Efficacy
Questionnaire. Br J
Ophthalmol, 2012;92(2):258-62. PMID: 21610264
Cox WC, Smith H, Blalock SJ. Predictors of academic difficulty
in a Doctor of Pharmacy
program. Int J Pharm Education, 2012;8(1). Available at:
http://www4.samford.edu/schools/pharmacy/ijpe/sp012/sp12.html
Casteel C, Blalock SJ, Ferreri S, Roth MT, Demby KB.
Implementation of a community
pharmacy-based falls prevention program. Am J Geriatr
Pharmacother, 2011;9(5):310-
9. PMID: 21925959
Sleath B, Blalock SJ, Covert D, Stone JL, Skinner AC, Muir K,
Robin AL. The relationship
between glaucoma medication adherence, eye drop technique, and
visual field defect
severity. Ophthalmol, 2011;118(12):2398-402. PMID: 21856009
Patterson ME, Blalock SJ, Smith AJ, Murray MD. Associations
between prescription
copayment levels and beta-blocker medication adherence in
commercially insured
heart failure patients 50 years and older. Clin Ther,
2011;33(5):608-16. PMID:
21665045
Blalock SJ. The theoretical basis for practice-relevant
medication use research: patient-
centered/behavioral theories. Res Soc Adm Pharm,
2011;7(4):317-29. PMID:21272552
Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC, Murray MD.
Risk of hyperkalemia
asssociated with selective cox-2 inhibitors. Pharmacoepidemiol
Drug Saf,
2010;19(11)1194-1198
Blalock SJ, Casteel C, Roth MT, Ferreri S, Demby KB, Shankar V.
Impact of enhanced
pharmacologic care on the prevention of falls: a randomized,
controlled trial. Am J
Geriatr Pharmacother 2010;8(5):428-440.
Farley JB, Wang C, Blalock SJ. The status of Ph.D. education in
economic, social, and
administrative sciences between 2005 and 2008. Am J Pharm Educ
2010;74(7):126
Blalock SJ, Demby KB, McCulloch KD, Stevens JA. Factors
influencing hip protector use
among community-dwelling older adults. Injury Prevention
2010;16(4):235-9.
Sleath B, Blalock SJ, Robin A, Hartnett ME, Covert D, DeVellis
B, Giangiacomo A.
Development of an instrument to measure glaucoma medication
self-efficacy and
outcome expectations. Eye, 2010;24(4):624-631.
Beard AJ, Sleath B, Blalock SJ, Roth M, Weinberger M, Tudor G,
Chewning B. predictors
of rheumatoid arthritis patient-physician communication about
medication costs during
visits to rheumatologists. Arthritis Care Res,
2010;62(5):632-9.
Hansen RA, Chin H, Blalock SJ, Joy MS. Pre-dialysis chronic
kidney disease: evaluation of
quality of life in clinic patients receiving comprehensive
anemia care. Res Soc Adm
Pharm, 2009;5(2):143-53.
Sleath B, Blalock SJ, Bender DE, Murray M, Cerna A, Cohen MG.
Latino patients'
preferences for medication information and pharmacy services. J
Am Pharm Assoc
2009;49(5):632-6.
Blalock SJ, Gregory, PJ, Patel, RA, Norton LL, Callahan LF,
Jordan JM. Factors associated
with potential medication-herb/natural product interactions in a
rural community.
Altern Ther Health Medicine, 2009;15(5):26-34.
Farley JF, Blalock SJ. Trends and determinants of prescription
anti-osteoporosis medication
Use. Am J Health Syst Pharm, 2009; 66(13):1191-201.
-
BLALOCK
5
Joyner PU, Thomason TE, Blalock SJ. Practice settings, job
responsibilities, and job
satisfaction of nontraditional PharmD and BS pharmacy graduates.
Am J Pharm Educ.
2009; 73(2):33.
Sleath B, Blalock SJ, Bender D, Murray M, Cerna A, Cohen MG.
Latino’ sources of
medication and medication information in the United States and
their home countries.
Patient Educ Couns. 2009; 75(2):279-82.
Blalock SJ, Demby KB, McCulloch KL, Stevens JA. Seniors’
perceptions of using hip
protectors to reduce fracture risk. J Am Geriatr Soc.
2008:56:1773-1774.
Ferreri S, Roth MT, Casteel C, Demby KB, Blalock SJ. Methodology
of an ongoing,
randomized controlled trial to prevent falls through enhanced
pharmaceutical care. Am J
Geriatr Pharmacother. 2008;6: 61-81.
Farley JF, Blalock SJ, Kline RR. Effect of the women’s health
initiative on prescription
anti-osteoporosis medication utilization. Osteoporos Int.
2008,19:1603-1612.
Thorpe CT, DeVellis RF, Blalock SJ, Hogan SL, Lewis MA, DeVellis
BM. Patients’
perceptions about illness self-management in anca-associated
small vessel vasculitis.
Rheumatology 2008; 47(6):881-6
Joyner PU, Cox WC, White-Harris C, Blalock SJ. The structured
interview and interviewer
training in the admissions process. Am J Pharm Educ.
2007;71:83.
Thorpe CT, DeVellis RF, Lewis MA, Blalock SJ, Hogan S, DeVellis
BM. Development and
initial evaluation of a measure of self-management for adults
living with anca-
associated small vessel vasculitis. Arthritis Rheum.
2007;5:1296-1302.
Blalock SJ. Predictors of calcium intake patterns: a
longitudinal analysis. Health Psychol.
2007;26(3):251-258. Thorpe JM, Sleath BL, Kalinowski CT,
VanHoutven CH, Blalock SJ, Landerman LR,
Campbell WH, Clipp EC. Caregiver psychological distress as a
barrier to vaccination for influenza among community-dwelling
elderly with dementia. Med Care. 2006;44(8):713-21.
Hansen RA, Greene SB, Williams CE, Blalock SJ, Crook KD, Akers
R, Carey TS. Types of
medications errors in North Carolina nursing homes: a target for
quality improvement.
Am J Geriatr Pharmacother. 2006;4(1):52-61.
Blalock SJ. Toward a better understanding of calcium intake:
behavioral change
perspectives. J Reprod Med. 2005;50:901-6.
Blalock SJ, Byrd JE, Hansen RA, Yamanis TJ, McMullin K, DeVellis
BM, DeVellis RF,
Panter AT, Kawata AK, Watson, LC, Jordan JM. Factors associated
with potentially
inappropriate drug utilization in a sample of community-dwelling
older adults. Am J
Geriatr Pharmacother. 2005;3:168-179.
Blalock SJ, Norton LL, Patel RA, Dooley MA. Patient knowledge,
beliefs, and behavior
concerning the prevention and treatment of
glucocorticoid-induced osteoporosis.
Arthritis Care Res. 2005;53:732-739.
Welch AC, Ferreri SP, Blalock SJ, Caiola SM. North Carolina
family practice physicians'
perceptions of pharmacists as vaccinators. J Am Pharm Assoc.
2005;45:486-491.
Blalock SJ, Patel RA. The Drug Therapy Concerns Scale: Initial
development and
refinement. J Am Pharm Assoc. 2005;45:160-169.
McIntosh J, Blalock SJ. Effects of media coverage of the Women’s
Health Initiative on the
attitudes and behavior of women regarding hormone replacement
therapy. Am J Health
Syst Pharm. 2005;62:69-74.
-
BLALOCK
6
Patel R, Carr-Lopez SM, Blalock SJ. Assessment of clinical
endpoints and medication
utilization in patients with type 2 Diabetes. J Air Force Pharm.
2004;11(2): 93-98.
Blalock SJ, Norton LL, Patel RA, Cabral K, Thomas CL.
Development and assessment of a
short instrument for assessing dietary intakes of calcium and
vitamin D. J Am Pharm
Assoc. 2003;43:685-693.
Blalock SJ, DeVellis BM, Patterson CC, Campbell MK, Orenstein
DR, Dooley MA. Effects
of an osteoporosis prevention program incorporating tailored
educational materials. Am
J Health Promot. 2002;16:146-156.
Knapp KK, Blalock SJ, Black B. ASHP survey of ambulatory care
responsibilities of
pharmacists in integrated health systems, 2001. Am J Health Syst
Pharm. 2001;58:
2151-2166.
Ainsworth BE, Anderson LA, Becker DM, Blalock SJ, Brown DR,
Brownson RC,
Brownstein N, Cornell CE, DeVellis BM, Finnegan LP, Folger S,
Fulton JE, Groff JY,
Herman C, Jones D, Keyserling TC, Koffman DM, Lewis C, Masse LE,
McKeown RE,
Orenstein D, Spadaro AJ. Community prevention study:
Contributions to women’s
health and prevention research. J Womens Health Gend Based Med
2001;10(10):913-
920
Blalock SJ, Currey SS, DeVellis RF, DeVellis BM, Giorgino KB,
Anderson JJB, Dooley
MA, Gold DT. Effects of educational materials concerning
osteoporosis on women’s
knowledge, beliefs, and behavior. Am J Health Promot.
2000;14:161-169.
Ferrill MJ, Blalock SJ, Norton LL. A survey of the literature
evaluation skills of health-
system pharmacists. Hosp Pharm. 2000;35:721-727.
Ferrill MJ, Norton LL, Blalock SJ. Determining the statistical
knowledge of pharmacy
practitioners: A survey and review of the literature. Am J Pharm
Educ. 1999;63:371-
376.
Blanchard LW, Blalock SJ, DeVellis RF, DeVellis BM, Johnson MR.
Social comparison
among mothers of premature and full-term infants. Child Health
Care. 1999;28:329-
348.
Knapp KK, Blalock SJ, O’Malley CH. ASHP survey of ambulatory
care responsibilities of
pharmacists in integrated health systems, 1999. Am J Health Syst
Pharm.
1999;56:2431-2443.
Blalock SJ, Orlando M, Mutran EJ, DeVellis RF, DeVellis BM.
Effect of satisfaction with
one’s abilities on positive and negative affect among
individuals with recently
diagnosed rheumatoid arthritis. Arthritis Care Res.
1998;11:158-165.
Blalock SJ, DeVellis RF. Health salience: Reclaiming a concept
from the lost and found.
Health Educ Res. 1998;13:399-406.
Blalock SJ, Currey SS, DeVellis RF, Anderson JJB, Gold DT,
Dooley MA. Using a short
food frequency questionnaire to estimate dietary calcium
consumption: A tool for
patient education. Arthritis Care Res. 1998;11:479-484.
DeVellis RF, Carl KL, DeVellis BM, Blalock SJ, Patterson CC.
Correlates of changes in
mood following a mood induction in osteoarthritis patients.
Arthritis Care Res.
1998;11:234-242.
DeVellis RF, Patterson CC, Blalock SJ, Renner BR, DeVellis BM.
Do people with
rheumatoid arthritis develop illness-related schemas? Arthritis
Care Res. 1997;10:78-
88.
-
BLALOCK
7
Callahan LF, Blalock SJ. Behavioral and social research in
rheumatology. Curr Opin
Rheumatol. 1997;9:126-32.
Blalock SJ, DeVellis RF, Giorgino KB, DeVellis BM, Gold DT,
Dooley MA, Anderson JJB,
Smith SL. Osteoporosis prevention in premenopausal women: Using
a stage model
approach to examine the predictors of behavior. Health Psychol.
1996;15:84-93.
Freeman JB, Blalock SJ, Holman HR, Liang MH, Meenan RF. Advances
brought by
healthservices research to patients with arthritis: Summary of
the workshop Health
Services Research in Arthritis: From research to practice.
Arthritis Care Res.
1996;9:142-150.
Blalock SJ, DeVellis BM, Giorgino KB. The relationship between
coping and
psychologicalwell-being among people with osteoarthritis: A
problem-specific
approach. Ann Behav Med. 1995;17:107-115.
Zautra AJ, Burleson MH, Smith CA, Blalock SJ, Wallston KA,
DeVellis RF, DeVellis BM,
Smith TW. Arthritis and the quality of life experience: An
examination of positive and
negative affect in rheumatoid arthritis patients. Health
Psychol. 1995;14:399-408.
Giorgino KB, Blalock SJ, DeVellis RF, DeVellis BM, Keefe FJ,
Jordan JM. Appraisal of
and coping with arthritis-related problems in three areas:
Household activities, leisure
activities, and pain management. Arthritis Care Res.
1994;7:20-28.
Upchurch G, Earp JA, Blalock SJ. Access to medications for low
income North Carolina
citizens: Without funds, how can they follow doctor's orders? N
C Med J. 1994;55:173-
177.
Blalock SJ, Bunker BJ, DeVellis RF. Measuring health status
among survivors of burn
injury: Revision of the Burn Specific Health Scale. J Trauma.
1994;6:508-515.
Blalock SJ, Bunker BJ, DeVellis RF. Psychological distress among
survivors of burn injury:
The role of outcome expectations and perceptions of importance.
J Burn Care Rehabil.
1994;15:421-427.
Blalock SJ, DeVellis BM, Holt K, Hahn PM. Coping with rheumatoid
arthritis: Is one
problem the same as another? Health Educ Q. 1993;20:119-132.
DeVellis BM, Blalock SJ. Illness attributions and hopelessness
depression: The role of
hopelessness expectancy. J Abnorm Psychol. 1992;101:257-264.
Blalock SJ, Bunker BJ, Moore JD, Foreman N, Walsh JF. The impact
of burn injury: A
preliminary investigation. J Burn Care Rehabil.
1992;13:487-492.
Blalock SJ, DeVellis BM, DeVellis RF, Giorgino KB, Sauter SVH,
Jordan JM, Keefe FJ,
Mutran EJ. Psychological well-being among people with
recently-diagnosed
rheumatoid arthritis: Do self-perceptions of abilities make a
difference? Arthritis
Rheum. 1992;35:1267-1272.
DeVellis RF, Blalock SJ, Holt K, Renner BR, Blanchard LW, Klotz
ML. Arthritis patients'
reactions to unavoidable social comparisons. Pers Soc Psychol
Bull. 1991;17:392-399.
DeVellis RF, Holt K, Renner BR, Blalock SJ, Blanchard LW, Cook
HL, Klotz ML, Mikow
V, Harring K. The relationship of social comparison to
rheumatoid arthritis symptoms
and affect. Basic Appl Social Psych. 1990;11:1-18.
DeVellis BM, Blalock SJ, Sandler RS. Predicting participation in
cancer screening: Testing
the theory of planned behavior. J Appl Soc Psychol.
1990;20:639-660.
Blalock SJ, Afifi RA, DeVellis BM, Holt K, DeVellis RF.
Adjustment to rheumatoid
arthritis: The role of social comparison processes. Health Educ
Res. 1990;5:361-370.
-
BLALOCK
8
Blalock SJ, DeVellis BM, Afifi RA, Sandler RS. Risk perceptions
and participation in
colorectal cancer screening. Health Psychol. 1990;9:792-806.
Blalock SJ, Sauter SVH, DeVellis RF. The Modified Health
Assessment Questionnaire
Difficulty Scale: A health status measure revisited. Arthritis
Care Res. 1990;3:182-188.
Blalock SJ, DeVellis BM, DeVellis RF. Social comparison among
individuals with
rheumatoid arthritis. J Appl Soc Psychol. 1989;19:665-680.
Sandler RS, DeVellis BM, Blalock SJ, Holland KL. Participation
of high risk subjects in
colon cancer screening. Cancer. 1989;63:2211-2215.
Blalock SJ, DeVellis RF, Brown GK, Wallston KA. Validity of the
Center for
Epidemiological Studies Depression Scale in arthritis
populations. Arthritis Rheum.
1989;32:991-997.
DeVellis BM, Blalock SJ, Hahn PM, DeVellis RF, Hochbaum GM.
Evaluation of a
problem-solving intervention for patients with arthritis.
Patient Educ Couns.
1988;11:29-42.
Blalock SJ, DeVellis BM, DeVellis RF, Sauter S. Self-evaluation
processes and adjustment
to rheumatoid arthritis. Arthritis Rheum. 1988;31:1245-1251.
Blalock SJ, DeVellis BM, Sandler RS. Participation in fecal
occult blood screening for
colorectal cancer: A critical review. Prev Med.
1987;16:9-18.
Blalock SJ, DeVellis BM. Stereotyping: The link between theory
and practice. Patient Educ
Couns. 1986;8:17-25
Refereed Presentations with Published Abstracts
Elstad E, Carpenter D, DeVellis R, Blalock S. The impact of
conflicting medication
information on patients’ trust in information sources. Ann Behav
Med 2011;41:S30.
Cohen MG, Sleath BL, Blalock S, Cerna AR, Bender DE. Latino’s
attitudes and preferences regarding treatment of hypertension.
Circulation. 2008;118(12):E297-298.
Thorpe CT, DeVellis RF, Lewis MA, Hogan SL, Blalock SJ, DeVellis
BM. Development and initial evaluation of a measure of
self-management for adults living with ANCA-associated small vessel
vasculitis. Arthritis Rheum. 2007;25(1):S115-S116.
Kelly KB, Ball AM, Miller AD, Haslam WD, Mangum L, Malone R,
Bryant B, Jones M,
Scott M, Cox W, Parker MH, Murray M, Blalock S, Adams P, Sueta
C, Rodgers JE. Impact of medication access on adherence and
outcomes of outpatients with heart failure. Pharmacotherapy.
2005;25(3):470.
Blalock SJ, Norton LL, Patel RA. Adherence to the American
College of Rheumatology Guidelines for the prevention and treatment
of glucocorticoid-induced osteoporosis. Arthritis Rheum.
2004;50:S682.
Welch A, Ferreri S, Caiola S, Blalock S. Physicians perceptions
of pharmacists as vaccinators. J Am Pharm Assoc.
2004;44(2):266.
Blalock SJ, Norton LL, Patel RA. Osteoporosis prevention among
people with rheumatoid arthritis receiving oral glucocorticoid
therapy. J Am Pharm Assoc. 2003;43(2):311-312.
Blalock SJ, Patel RA. The Drug Therapy Concerns Scale: Findings
from the initial scale development phase. J Am Pharm Assoc.
2003;43(2):316.
Blalock SJ. Women’s knowledge and beliefs concerning estrogen
and osteoporosis risk-
reduction. J Am Pharm Assoc. 2001;41(2):312.
-
BLALOCK
9
Blalock SJ, Patterson CC, Dooley MA, DeVellis RF, Orenstein D.
Women’s knowledge and
beliefs concerning estrogen and osteoporosis risk-reduction.
Arthritis Care Res. 1998;
11:S8.
Blalock SJ, Currey SS, DeVellis RF, DeVellis BM, Dooley MA.
Effects of educational
materials concerning osteoporosis on women’s knowledge, beliefs,
and behavior.
Arthritis Care Res. 1998;11:S7.
Blalock SJ, Smith SL: Osteoporosis prevention. Longitudinal
predictors of behavior change.
Arthritis Rheum. 1997;40(9):S319.
Dooley MA, Giorgino KB, Blalock SJ, DeVellis RF, Estrada A, Rice
JR. Validation of a
self-administered screening instrument for fibromyalgia.
Arthritis Rheum.
1997;40(9):S129.
Smith SL, Blalock SJ. Predictors of reading educational
materials about osteoporosis
prevention. Arthritis Rheum.1996;39(9):S125.
Giorgino KB, DeVellis RF, Blalock SJ, Rice JR, Dooley MA.
Assessing the feasibility of a
self-administered screening instrument for fibromyalgia.
Arthritis Rheum. 1996;
39(9):S322.
Blalock SJ, DeVellis RF. Development of a measure to assess
general health motivation.
Arthritis Rheum. 1995;38:S319.
Blalock SJ, DeVellis RF, Giorgino KB, DeVellis BM, Gold DT,
Dooley MA, Anderson
JJB,Smith SL. Osteoporosis prevention: Using a stage model
approach to examine the
predictors of exercise activity and calcium consumption.
Arthritis Rheum.
1995;38:S311.
Blalock SJ, DeVellis RF, DeVellis BM, Giorgino KB, Mutran EJ.
The relationship
betweendepression and physical functioning in rheumatoid
arthritis. Arthritis Care Res.
1992;5:S8.
Fifield J, Reisine S, Blalock SJ, DeVellis RF, Allaire SH.
Psychosocial theories in arthritis
research: A multidisciplinary approach. Arthritis Care Res.
1991;4:S16.
Blalock SJ, DeVellis BM, DeVellis RF, Giorgino KB, Sauter S,
Keefe FJ. An examination
of self-evaluation processes among individuals with
recently-diagnosed rheumatoid
arthritis. Arthritis Care Res. 1991;4:S21.
Giorgino KB, Blalock SJ, DeVellis BM, DeVellis RF. The nature of
social and
temporalcomparisons made by individuals with recently diagnosed
rheumatoid arthritis.
Arthritis Care Res. 1991;4:S14.
Patterson CC, Healy JC, DeVellis RF, Blalock SJ. What RA
patients think about, that
theirdoctors may not know. Arthritis Care Res. 1991;4:S14.
Giorgino KB, Blalock SJ, DeVellis BM, Jordan J, DeVellis RF.
Methods to minimize
attrition in longitudinal studies. Arthritis Care Res.
1991;4:S28.
Blalock SJ, Sauter SVH, DeVellis RF. Assessment of functional
capacity and actual function
using self-report measures. Arthritis Care Res. 1989;2:S22.
Sauter SVH, Blalock SJ, DeVellis RF. Assessment of function in
OA by significant others.
Arthritis Rheum. 1989;32:S99.
Blalock SJ, DeVellis RF. Validity of the Center for
Epidemiological Studies Depression
Scale in arthritis populations. Arthritis Rheum.
1988;31:S156.
-
BLALOCK
10
DeVellis RF, Blalock SJ, Holt K, Renner BR, Blanchard LW, Cook
HL. Effects of
socialcomparisons provided to rheumatoid arthritis patients.
Arthritis Rheum. 1988;31:
S157.
Sandler RS, DeVellis BM, Blalock SJ, Holland KL. Participation
of high-risk subjects in
colon cancer screening. Gastroenterology. 1988;94(5):A398.
Blalock SJ, DeVellis BM, DeVellis RF. Role of social comparison
in self-evaluation of
ability. Arthritis Rheum. 1987;30:S198.
DeVellis RF, Blalock SJ. Development and validation of
psychosocial measures in
arthritis.Arthritis Rheum. 1986;29:S145.
Blalock SJ, DeVellis BM, Hahn PM. Predictors of adjustment to
rheumatoid arthritis.
Arthritis Rheum. 1985;29:S176.
Other Presentations
Blalock SJ, Chewning B, Raynor DKT, Sleath BL. Improving
communication of medication
harms and benefits to patients: Research-based developments from
the UK and USA.
Symposium to be presented at the International Conference on
Communication in
Healthcare, St. Andrews, Scotland, September 2012.
Blalock SJ, Sleath BL, Hunter J, Revollo J, Chandiramani D.
Communicating risks
associated with prescription medications. Paper presented at the
International
Conference on Communication in Healthcare, Chicago, IL, October
2011.
Leone AL, Ives TJ, Blalock SJ. Pharmacotherapeutic treatment of
anxiety disorders:
investigating the correlation between GAD-7, PHQ-9, and Brief
Pain Inventory scores.
Paper presented at the American College of Clinical Pharmacy
Spring Practice
and Research Forum, Charlotte, NC, April 2010
Cohen MG, Sleath BL, Blalock SJ, Cerna AR. Latino’s attitudes
and preferences regarding treatment of hypertension. Paper
presented at the World Congress of Cardiology, Buenos Aires,
Argentina, May 2008.
Blalock SJ. Preventing falls through enhanced pharmaceutical
care. Paper presented at the
National Injury and Violence Prevention Research Conference.
Society for the
Advancement of Injury and Violence Research, September 2007,
Columbus, OH, GA.
Blalock SJ. Preventing falls through enhanced pharmaceutical
care. Paper presented at the
Unintentional Injury/Falls Related Research Grantee Meeting,
sponsored by the Centers
for Disease Control and Prevention, May 7-8, 2007, Atlanta,
GA.
Blalock SJ. Patient perceptions of using hip protectors to
reduce fracture risk. Paper
presented at the Unintentional Injury/Falls Related Research
Grantee Meeting,
sponsored by the Centers for Disease Control and Prevention, May
7-8, 2007, Atlanta,
GA.
Blalock SJ, Brock T, Sleath B. Bringing theory to life. Workshop
conducted at the 14th
International Social Pharmacy Conference, St. Anne’s College,
Oxford, July 2006.
Ferrill MJ, Brown DL, Blalock SJ. The determinants of teaching
effectiveness: A survey of
2004 teachers of the year. American Association of Colleges of
Pharmacy Annual
Meeting, Cincinnati, July 2005.
-
BLALOCK
11
Blalock SJ, Patel RA. Development of an instrument to assess
subjective drug therapy
concerns. Poster presentation at the130th
Annual Meeting and Exposition of the
American Public Health Association, Philadelphia, November
2002.
Blalock SJ. Structural equation modeling with latent variables:
Issues and applications.
Podium presentation at the Annual Meeting of the American
College of Clinical
Pharmacy, Los Angeles, November 2000.
Blalock SJ, Bunker BJ, DeVellis, RF. Measurement of health
status among survivors of
burn injuries. Podium presentation at the 120th
Annual Meeting and Exposition of the
American Public Health Association, Atlanta, November 1992.
Blalock SJ, Bunker BJ, Moore JD, Foreman N. Rehabilitation from
burn injury. Podium
presentation at the 119th
Annual Meeting and Exposition of the American Public Health
Association, Atlanta, November 1991.
Blalock SJ, DeVellis BM, Holt K, Hahn PM. Assessment of coping
among individuals with
rheumatoid arthritis. Podium presentation at the 119th
Annual Meeting and Exposition
of the American Public Health Association, Atlanta, November
1991.
Blalock SJ, Sauter SVH, DeVellis RF. Conceptual issues in the
measurement of health
status: An empirical investigation. Podium presentation at the
10th
Annual Meeting of
the Society of Behavioral Medicine, San Francisco, April
1989.
DeVellis BM, Blalock SJ. Coping processes and adjustment to
rheumatoid arthritis. In: TA
Revenson and KA Wallston (Symposium Chairs), Adaptation to
chronic illness:
Rheumatoid arthritis as exemplar. Podium presentation at the
97th
Annual Convention
of the American Psychological Association, New Orleans, August
1989.
DeVellis BM, Blalock SJ, Holland KL, Sandler RS. Determinants of
colorectal cancer
screening among those at high risk. Podium presentation at the
9th
Annual Meeting of
the Society of Behavioral Medicine, Boston, April 1988.
Sandler RS, DeVellis BM, Blalock SJ, Holland KL. High risk
subjects in colon cancer
screening. Podium presentation at the Annual Meeting of the
American
Gastroenterological Association, New Orleans, May 1988.
Blalock SJ, DeVellis BM, DeVellis RF. Social comparisons among
individuals with
rheumatoid arthritis. Podium presentation at the 8th
Annual Meeting of the Society of
Behavioral Medicine, Washington DC, March 1987.
Blalock SJ, DeVellis BM, DeVellis RF. Social comparison
processes and adjustment to
rheumatoid arthritis. Podium presentation at the 95th
Annual Convention of the
American Psychological Association, New York City, August
1987.
Blalock SJ. Adjustment to illness through social comparison. In:
BM DeVellis (Symposium
Chair), Applying psychosocial theory to practice: Promises and
pitfalls. Podium
presentation at the Society of Public Health Education Midyear
Scientific Meeting,
Chapel Hill, North Carolina, June 1986.
DeVellis BM, Blalock SJ, Hahn PM. Theory based interventions in
rheumatoid arthritis.
Podium presentation at the 93rd
Annual Convention of the American Psychological
Association, Los Angeles, August 1985.
Hahn PM, Blalock SJ, DeVellis BM. Use of a problem solving
intervention with patients
with rheumatoid arthritis. Podium presentation at the 113th
Annual Meeting and
Exposition of the American Public Health Association, Washington
DC, November
1985.
-
BLALOCK
12
-
BLALOCK
13
TEACHING RECORD
Classroom Teaching: Classes that include coordination
responsibilities
Course Role Semesters
Drug Literature Analysis and Interpretation
(Pharm 433)
School of Pharmacy
University of North Carolina at Chapel Hill
Course Coordinator
Instructor
Fall 2003-10
Fall 2002
Social & Behavioral Aspects of Pharmaceutical Use
(DPOP 803)
School of Pharmacy
University of North Carolina at Chapel Hill
Co-Course
Coordinator
Spring 2005
Spring 2007
Spring 2009
Spring 2011
Patient-Reported Outcomes: Theory, Methods, and
Applications
(DPOP 805)
School of Pharmacy
University of North Carolina at Chapel Hill
Co-Course
Coordinator
Spring 2004
Spring 2006
Applied Pharmaceutical Statistics
(Pharm 192)
School of Pharmacy
University of North Carolina at Chapel Hill
Instructor Fall 2002
Statistics and Experimental Design
(PCSP 201)
TJ Long School of Pharmacy
University of the Pacific
Co-Course
Coordinator
Summer 2002
Pharmacy Systems and Experiences V
(Phar 151)
TJ Long School of Pharmacy
University of the Pacific
Course Coordinator Spring 2000-
02
Pharmaceutical Calculations and Statistics
(Phar 112)
TJ Long School of Pharmacy
University of the Pacific
Course Coordinator Fall 1999-
2001
-
BLALOCK
14
Course Role Semesters
Contemporary Pharmacy Practice
(Phar 162)
TJ Long School of Pharmacy
University of the Pacific
Course Coordinator Spring 1999
Doctoral Seminar: Professional issues
(HBHE 312)
School of Public Health
University of North Carolina at Chapel Hill
Co-Course
Coordinator
Fall 1998
Fall 1996
Social and Behavioral Science Foundations of
Health Education
(HBHE 130)
School of Public Health
University of North Carolina at Chapel Hill
Course Coordinator
Guest Lecturer
Fall 1993
Fall 1984-98
Fall 2009-10
Classroom Teaching: Guest Lectures
Course Semesters
Injury and Violence (EPID 783)
2006, 07, 09, 11
Dietary Change Interventions (NUTR 715) 2009
Special Topics in Health Policy and Administration: Proposal
writing (HPAA 872) 2006-2009
Ethics in Research (PHCY 801) 2007-08
Pharmaceutical Care Lab V (PHCY 405) 2007-08
Aging and Health (EPID 604) Fall 2005-07
-
BLALOCK
15
Dissertation Committees
Student: Dissertation Title Department1 Committee
Role Year
Christopher Gillette: The Effect of Risk, Side Effect, and
Benefit Communication on Asthma Control
Medication Adherence in Pediatric Patients
DPOP Member Current
Walter Palmer: Evaluation of the Matter of Balance Program
HMSC Member Current
Deidre Washington: The Effect of Patient’s Race on
Patient-Provider Communication with Pediatric Asthma
Patients
DPOP Chair 2010
Hisham Aljadhey: The effects of nonsteroidal anti-inflammatory
drugs (NSAIDs) on blood pressure, renal
function, and serum potassium concentrations.
DPOP Member 2008
Ashley Beard: Cost as a feature of medication management
communication in medical visits.
DPOP Member 2008
John Byrd: Impact of medication stressors on emotional health of
informal caregivers of demented
patients.
DPOP Member 2007
Suzanne Cadarette: Barriers to and facilitators of osteoporosis
investigation and treatment among older
community-dwelling women in Ontario: Application of
a health services utilization conceptual framework.
University
of Toronto
External
Reviewer
2006
Mark Patterson: Effect of prescription copayments on medication
persistence and hospitalizations in
commercially insured patients with heart failure.
DPOP Member 2006
Carolyn Thorpe: Treatment adherence among adults living with
ANCA small vessel vasculitis.
HBHE Member 2006
Joshua Thorpe: Health care utilization in community-dwelling
persons with dementia: The role of informal
caregiver emotional health.
DPOP Member 2005
Suzanne Folger: Exploring risk factors for respiratory
illnesses: Are children who live near waste
incinerators at increased risk?
EPID Member 1996
Kathryn Luchok: Social support and women's health during
pregnancy and postpartum among the Yoruba of
Nigeria.
HBHE Member 1993
1 HBHE: Department of Health Behavior and Health Education, UNC
School of Public Health; DPOP: Division
of Pharmaceutical Outcomes and Policy, UNC Eshelman School of
Pharmacy; EPID: Department of
Epidemiology, UNC School of Public Health; HMSC: Human Movement
Science, Department of Allied Health
Science, UNC School of Medicine.
http://proquest.umi.com.libproxy.lib.unc.edu/pqdweb?index=0&did=1629574721&SrchMode=2&sid=9&Fmt=2&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1235886633&clientId=15094http://proquest.umi.com.libproxy.lib.unc.edu/pqdweb?index=0&did=1629574721&SrchMode=2&sid=9&Fmt=2&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1235886633&clientId=15094
-
BLALOCK
16
Masters Committees
Student: Project Title Department1 Committee
Role Year
Kim Faurot: The role of the community pharmacist in dietary
supplement education: An
exploratory study.
HBHE Reader 2005
Kara Suter: The effect of health literacy on outcomes.
DPOP Chair 2003
Angela DeVeaugh-Geiss: Factors influencing family physician
counseling about folic acid and
neural tube defects.
DPOP Reader 2003
Gina Upchurch: Access to medications for North Carolina's
indigent population: A policy
analysis.
HBHE Reader 1993
Jerrel Moore: Attributions, learned helplessness, and problem
solving in rheumatoid arthritis
patients.
HBHE Reader 1988
1 HBHE: Health Behavior and Health Education, UNC School of
Public Health; DPOP: Pharmaceutical
Outcomes and Policy, UNC Eshelman School of Pharmacy.
Academic Advisor: PhD
Anne Beaubrun, 2008-2011
Deidre Washington, 2005-2010
Stacie Dusetzina, 2006-2008
Melissa Butler: 2003-2008
Mark Patterson: 2002-2003
Academic Advisor: PharmD
PharmD Classes of 2008, 2013, 2014: Approximately 12
advisees/class
Pharmacy Residents
Teresa Anderson, PharmD, 2006-07
Stephen Stricker, PharmD, 2006-07
Amanda Whitehead, PharmD, 2005-06
Ashley McNeill, PharmD, 2005-06
Amanda Lehenbauer, PharmD, 2005-06
Adam Welch, PharmD, 2004-05
Jennifer McIntosh, PharmD, 2002-03
Independent Study
Helen Smith, Spring 2008
Renee Howard, Academic Year 2006-07
Annie Yi, Spring 2007
Leslie Pritchard, Fall 2004
Amar Vyas: Academic Year 2004-05
-
BLALOCK
17
GRANTS AND CONTRACTS
PRINCIPAL INVESTIGATOR (PRIME)
Project Information Approx. Total
Direct Costs
Communicating Risks Associated with Prescription Medications
American College of Rheumatology Research and Education
Foundation
2010-2012
$367,000
Medication Therapy Management: Older adult and pharmacist
perceptions
University Research Council
2006-08
$4,500
Osteoporosis Prevention among People with Rheumatoid
Arthritis
Receiving Oral Glucocorticoid Therapy
Arthritis Foundation
July 2000-June 2005
$400,000
Health Outcomes and Patient Education Project: The Carolina
Community Pharmacy Patient Panel
UNC-CH School of Pharmacy Faculty Seed Grant
May 2004-April 2005
$8,400
Development of the Pharmaceutical Care Concerns Scale
Scholarly and Artistic Activity Grant, University of the
Pacific
September 1999-August 2000
$1,885
Coping with Osteoarthritis: An examination of strategies used to
deal
with four illness-related problems
Arthritis Foundation
1991-94
$75,000
Self-Care Education for Medication Use Manual
North Carolina Department of Environment, Health and Natural
Resources
1990-91
$4,250
Self-Evaluation of Functional Abilities Among Patients with
Rheumatoid Arthritis
Arthritis Health Professions Traineeship
1985-87
$32,000
-
BLALOCK
18
PRINCIPAL INVESTIGATOR ON PROJECTS WITHIN CENTER GRANTS
Project Information Approx. Total
Direct Costs
Translational Research to Identify Factors Related to Older
Adult Use
of Evidence-Based Falls Prevention Programs
Project within UNC Injury Prevention Research Center (IPRC)
Centers for Disease Control and Prevention
IPRC Principal Investigator: Carol W. Runyan, PhD
Interim IPRC Director: Stephen Marshall, PhD
June 2011-July 2013
$200,000
Preventing Falls Through Enhanced Pharmaceutical Care
Project within UNC Injury Prevention Research Center (IPRC)
Centers for Disease Control and Prevention
IPRC Principal Investigator: Carol W. Runyan, PhD
August 2004-July 2009
$730,000
Patient Perceptions of Using Hip Protectors to Reduce Fracture
Risk
Project within UNC Injury Prevention Research Center (IPRC)
Centers for Disease Control and Prevention
IPRC Principal Investigator: Carol W. Runyan, PhD
August 2004-July 2005
$69,000
Osteoporosis Prevention: Education and outreach
Project within UNC Health Promotion and Disease Prevention
Center
(HPDP)
Centers for Disease Control and Prevention
HPDP Principal Investigator: Carl Cross, MD
October 1995-September 1998
$580,000
Osteoporosis Prevention: Application and testing of the
Precaution
Adoption Process
Project within UNC Multipurpose Arthritis Research Center
National Institute of Arthritis and Musculoskeletal and Skin
Diseases
Center Principal Investigator: John B. Winfield, MD
1993-96
$308,000
Genetic Testing for Breast Cancer Susceptibility: An exploratory
study
of educational issues
Project within UNC Breast Cancer Specialized Programs of
Research
Excellence (SPORE)
National Cancer Institute
SPORE Principal Investigator: Edison Liu, MD
1994-96
$27,000
Adjustment to Rheumatoid Arthritis: The role of the
self-evaluation
processes
$300,000
-
BLALOCK
19
Project within UNC Multipurpose Arthritis Research Center
National Institute of Arthritis and Musculoskeletal and Skin
Diseases
Center Principal Investigator: John B. Winfield, MD
1988-92
Determinants of Burn Rehabilitation
Project within UNC Injury Prevention Research Center
(IPRC)
Centers for Disease Control and Prevention
IPRC Principal Investigator: Carol W. Runyan, PhD
1990-92
$90,000
DIRECTOR OF CORES WITHIN CENTER GRANTS
Project Information Approx. Total
Direct Costs
Numerical Sciences Core
Core within UNC Multipurpose Arthritis Research Center
National Institute of Arthritis and Musculoskeletal and Skin
Diseases
Center Principal Investigator: John B. Winfield, MD
1993-98
$555,000
PRINCIPAL INVESTIGATOR ON SUBCONTRACTS
Project Information Approx. Total
Direct Costs
Consumer Assessment of Pharmacist/Pharmacy Services
American Institutes for Research (Prime: Pharmacy Quality
Alliance)
2007
$22,000
SENIOR INVESTIGATOR (MENTOR)
Project Information Approx. Total
Direct Costs
Anti-osteoporosis Medication Trends and Determination in the
US
Ambulatory Population from 1996-2004: Results from the
Medical
Expenditure Panel Survey (MEPS)
Principal Investigator: Joel Farley, PhD
American Society of Health-System Pharmacists
2006-08
$17,000
-
BLALOCK
20
CO- INVESTIGATOR
Project Information Approx. Total
Direct Costs
Communication About Glaucoma and Patients Outcomes
Principal Investigator: Betsy Sleath, PhD
National Eye Institute
2009-13
$1,790,000
Closing the quality gap series: revisiting the state of the
science quality
improvement interventions and/or programs to improve
prescription
medication adherence
Principal Investigator: Carol Golin, MD
Research Triangle Institute (Prime: AHRQ)
2010-11
$108,000
Determining the Effects of Conflicting Medication Information
and
Spouse Support on the Medication Adherence of Osteoarthritis
Patients
Principal Investigator: Delesha Miller, PhD
Novartis
2010
$85,000
The Effect of Medicaid Prescription Restrictions on Mental
Health
Utilization
Principal Investigator: Joel Farley, PhD
Pfizer, Inc.
2007-09
$130,000
Enhancing Pneumococcal Vaccination Rates through Community
Pharmacist Involvement
Principal Investigator: Stefanie Ferreri, PharmD
Centers for Disease Control and Prevention
October 2005-September 2007
$185,000
Wisewoman Medication Empowerment Module
Principal Investigator: Thomas Keyserling, MD
Centers for Disease Control and Prevention
2006
$12,000
The Impact of Traumatic Spinal Cord Injury: Development of a
system
to assess long-term health outcomes and patterns of health
service
utilization
Principal Investigator: Michael Y. Lee, MD
Centers for Disease Control and Prevention
1994-96
$108,000
-
BLALOCK
21
Selective Remembering of Information by Arthritis Patients
Project within UNC Multipurpose Arthritis Research Center
Project Principal Investigator: Robert F. DeVellis, PhD
Center Principal Investigator: John B. Winfield, MD
National Institute of Arthritis and Musculoskeletal and Skin
Diseases
1988-93
$335,000
Validity of Self-Report Measures of Functional Ability and
Actual
Function
Principal Investigator: Suzanne Sauter, MD
University of North Carolina Medical Faculty Grant
1988-89
$3,000
Self-Evaluation of Physical Abilities
Principal Investigator: Brenda M. DeVellis, PhD
University of North Carolina Research Council Grant
1985-87
$1,500
PROFESSIONAL SERVICE
SERVICE AT NATIONAL/INTERNATIONAL LEVEL
Invited Presentations
Communicating risks associated with prescription medications.
American
College of Rheumatology Foundation: Within Our Reach
Investigators
Meeting, Santa Fe, NM
January
2012
Communicating risks associated with prescription medications.
American
College of Rheumatology Foundation: Within Our Reach
Investigators
Meeting, Miami, FL.
June 2011
Comparative effectiveness research in community pharmacy
settings.
Chapel Hill Drug Conference, Chapel Hill, NC.
May 2011
Communicating risks associated with prescription medications: A
fuzzy
trace approach. Worldwide Universities Working Conference,
Sydney,
Australia.
May 2010
The Theoretical Basis for Practice-Relevant Medication Use
Research.
Presented at the Conference on Enhancing the Rigor and Utility
of
Medication Use Research. Co-sponsored by the American
Association of
Colleges of Pharmacy, the International Society of
Pharmacoeconomics and
Outcomes Research, the Pharmacy Practice Research Alliance, and
the US
Pharmacopeia.
January
2009
-
BLALOCK
22
Physician-Patient Communication: The case of osteoporosis.
Congressional Briefing, Rayburn Building, Washington DC. Hosted
by the
Alliance on Aging.
May 2005
Calcium compliance: Insights from past research. Calcium for
Life
Roundtable Meeting, New York City. Hosted by Innovative
Science
Solutions, SENSEI Health, and GSK.
June 2004
Osteoporosis prevention among people with rheumatoid arthritis
receiving
oral glucocorticoid therapy: Research in progress. Podium
presentation at
the Arthritis Foundation Grant Forum conducted in conjunction
with the
Annual Scientific Meeting of the Association of Rheumatology
Health
Professionals, San Francisco.
November
2001
Osteoporosis prevention: Strong Bones for Life Project.
Presentation for
the 50+ and Strong Alliance, Walnut Creek, CA.
January
2001
Addressing the effectiveness of community outreach interventions
for
women in improving osteoporosis prevention behaviors. Podium
presentation at the Community Prevention Research in Women’s
Health
Conference, Sponsored by the National Institutes of Health,
Washington DC.
October
2000
In Search of Clinical Relevance Workshop. (Speaker) Presented at
the
Annual Scientific Meeting of the Association of Rheumatology
Health
Professionals, Boston.
November
1999
Workshop for Health Services Research in Arthritis: From
research to
practice. (Co-Chair) Sponsored by The National Advisory Board
for Arthritis
and Musculoskeletal and Skin Diseases and The National Institute
of Arthritis
and Musculoskeletal and Skin Diseases. Bethesda, MD.
April 1994
Psychosocial models underlying patient coping. Podium
presentation at the
Workshop for Health Services Research in Arthritis: From
research to
practice. Sponsored by The National Advisory Board for Arthritis
and
Musculoskeletal and Skin Diseases and The National Institute of
Arthritis
and Musculoskeletal and Skin Diseases, Bethesda, MD.
April 1994
Committee Memberships
American Pharmacists Association Social and Administrative
Sciences
Graduate Program Committee
2010-11
Ad hoc Committee on Patient-Based Research, American College
of
Rheumatology
1999-2000
Research Committee, Association of Rheumatology Health
Professionals 1998-2000
Program Planning Committee, Association of Rheumatology
Health
Professionals
1990-91
-
BLALOCK
23
Editorial Boards and Service
Current Rheumatology Reviews 2004-
Present
Arthritis Care and Research 1995-2001
Arthritis Care and Research, Guest Editor, Special issue on
patient and
public health education
1998
Arthritis Care and Research, Guest Editor, Special issue on
health status
assessment
1992
Manuscript Review for Professional Journals (Since 2007)
Arthritis and Rheumatism
2007-
Present
Journal of the American Pharmacists' Association
2007-
Present
Osteoporosis International
2008-
Present
BMC Public Health 2010
Annals of Behavioral Medicine 2010
Annals of Internal Medicine 2010
International Journal of Injury Control and Safety 2010
Journal of Behavioral Medicine
2008-09
American Journal of Preventive Medicine 2007 & 09
American Journal of Public Health 2008
Journal of the American Geriatrics Society 2007
Journal of Womens Health 2007
American Journal of Managed Care Pharmacy 2007
Abstract Review for Annual Meetings
American Pharmacists' Association Annual Meeting 2004-
Present
International Society for Pharmacoeconomics and Outcomes
Research.
Quality of Life Panel
2002-03
-
BLALOCK
24
Association of Rheumatology Health Professionals. Research
Methods
Panel
2000
Grant Review
Agency for Healthcare Research and Quality. Clinical and
Health
Outcomes Initiative in Comparative Effectiveness (CHOICE)
Grants
(R01) (Member of scientific review panel)
2010
American College of Rheumatology. REF Study Section (Chaired
study
section in 2007 and 2008)
2006-
2008
Arthritis Foundation. Clinical Sciences Section (Ad hoc
reviewer) 2004
Association of Rheumatology Health Professionals: Pre-review
panel for
Arthritis Foundation grant proposals
2002
Arthritis Foundation. Clinical Sciences Study Section 1994-
97
National Institute of Arthritis and Musculoskeletal and Skin
Diseases,
NIAMS Centers Working Group 1. Ad hoc advisory group assembled
to
provide advice concerning the Research Centers funding
mechanism
1996
National Institute of Arthritis and Musculoskeletal and Skin
Diseases
(NIAMS). Member of site visit team, University of California -
Los
Angeles
1992
SERVICE TO THE STATE OF NORTH CAROLINA (2002-PRESENT)
North Carolina Falls Prevention Coalition, Chair of
Community
Awareness and Education Working Group
2008-10
Scientific review of materials created as part of Project
Lazarus in
Wilkes County (Materials designed to reduce mortality from
opiod
overdose)
2009
Communicating information concerning medication risks.
Continuing
education session presented at the Northwest Area Health
Education
Center, Winston Salem
November,
2009
Member of Medication Therapy Management Taskforce of North
Carolina Association of Pharmacists
2007
Carolina Center for Public Service, Member of Peck Elementary
Grant
Writing Seminar Team 2004-05
-
BLALOCK
25
SERVICE TO THE STATE OF CALIFORNIA (1998-2002)
California Breast Cancer Research Council 1999-2002
California Breast Cancer Research Council, Evaluation and
Priority
Setting Subcommittee (Chair)
2001-02
SERVICE TO UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Injury Prevention Research Center
Member of Core Faculty Group 2004-Present
Chair of Faculty Small Grants Review Committee 2009-10
Member of Biostatistical Core Review Working Group 2009-10
Reviewer for Susan P. Baker Student Research Paper Prize
2004-10
Chair of Dissemination Research Solicitation Committee
2005-06
Health Promotion and Disease Prevention Center
Member of Scientific Advisory Committee 2004-Present
Other
Review Committee for Dean John Williams, School of Dentistry
2009
Review Committee for Carol Runyan, Director of the UNC
Injury
Prevention Research Center 2009
UNC Tomorrow Campus Response Committee (Health) 2008
-
BLALOCK
26
SERVICE TO UNC ESHELMAN SCHOOL OF PHARMACY
School of Pharmacy Standing Committees
Graduate Education Committee: Divisional Director of
Graduate
Studies
2006-09
2011-Present
Community Pharmacy Advisory Committee 2007-09
Assessment Committee 2005
Admissions Committee 2003-06
2009-10
Honors Committee 2002-06
2009-11
Scholarship Committee 2002-06
School of Pharmacy Ad Hoc Committees
ACPE Self-Study Steering Committee: Chair of Mission,
Planning
and Evaluation Subcommittee 2010-12
Planning Committee: Asheville Satellite Program 2010-11
Planning Committee: Rural Pharmacy Health Initiative 2010-11
Search Committee: DPOP Faculty 2006-07
2010-11
Search Committee: Associate Dean for Research and Graduate
Education 2007
Search Committee: Assessment Director 2007
Search Committee: Director of Pharmaceutical Care Labs 2004
Search Committee: Pharmaceutical Policy and Evaluative
Sciences
Chair 2004
Planning Committee: Inaugural Research Conference 2002
Other
Faculty Delegate, American Association of Colleges of Pharmacy
2004-05
Faculty Council 2008-11
Mentor Committee for Joel Farley, PhD 2006-Present
Consultation to faculty in area of measurement and data analysis
2002-Present
-
BLALOCK
27
PROFESSIONAL AFFILIATIONS
American Pharmaceutical Association
American Public Health Association
Association of Rheumatology Health Professionals
RESEARCH AND TEACHING INTERESTS
Risk communication
Falls prevention
Evaluation of health promotion and disease management
programs
Health outcomes assessment
Patient decision-making and compliance with therapeutic
regimens
Psychosocial aspects of chronic illness